FRESH-PEF174-en
Enfants - Parents - Trouble déficit de l’attention avec Hyperactivité : Impact et Evaluation
EMPATHIE
| Name | Country code |
|---|---|
| France | fr |
['Clinical data','Participant-reported health data']
Individuals
| Topic | Vocabulary |
|---|---|
| Neurology | health theme |
| Paediatrics | health theme |
| Psychiatry | health theme |
| Attention deficit hyperactivity disorder, combined presentation | cim-11 |
| Socio-demographic and economic determinants | health determinant |
['Hauts-de-France']
{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Child (6 to 12 years)","concept":{"vocab":"MeSH","vocabURI":"D002648"}},{"value":"Adolescent (13 to 18 years)","concept":{"vocab":"MeSH","vocabURI":"D000293"}}],"level_type_clusion_I":"General population","level_type_clusion_other":"","clusion_I":"Inclusion criteria for parents/tutors: - Parents (father, mother or tutors) of a child aged 6 to 18 years suffering from ADHD - Parents (father, mother, or tutors) accompanying their ADHD children for a routine consultation during the observation period, - Parent (father, mother or tutor) of an child whether or not treated for his/her ADHD. Inclusion criteria for siblings: - Brother or sister without ADHD of a child corresponding to the aforementioned criteria, - Brother or sister at least 9 years old and living with the ADHD child. ","clusion_E":" ADHD child with important co-morbidity that could influence assessment of ADHD impact on psycho-socio-economic value, - Patients sibling / parents with important co-morbidity that could influence the evaluation of their experience (i.e. at the level of the socio-psycho-economic impact), - Parents unable to complete a self-questionnaire, - Parents who participated to the feasability study (interviews)"}
| Name |
|---|
| Anne;PONTHIEUX |
| Name | Role |
|---|---|
| NOVARTIS PHARMA SAS | sponsor |
| Name |
|---|
| NOVARTIS PHARMA SAS |
| Agency name |
|---|
| CNIL |
['Through organizations (health services or institutions, schools, businesses, etc.)']
['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 2007-01-01 | 2008-01-01 |
One-time cross-sectional study
{"value":"To be defined","extLink":[]}
| Name | |
|---|---|
| Anne;PONTHIEUX | anne.ponthieux@novartis.com |